title: The CDK4-pRB-E2F1 pathway controls insulin secretion.
abstract: CDK4-pRB-E2F1 cell-cycle regulators are robustly expressed in non-proliferating beta cells, suggesting that besides the control of beta-cell number the CDK4-pRB-E2F1 pathway has a role in beta-cell function. We show here that E2F1 directly regulates expression of Kir6.2, which is a key component of the K(ATP) channel involved in the regulation of glucose-induced insulin secretion. We demonstrate, through chromatin immunoprecipitation analysis from tissues, that Kir6.2 expression is regulated at the promoter level by the CDK4-pRB-E2F1 pathway. Consistently, inhibition of CDK4, or genetic inactivation of E2F1, results in decreased expression of Kir6.2, impaired insulin secretion and glucose intolerance in mice. Furthermore we show that rescue of Kir6.2 expression restores insulin secretion in E2f1(-/-) beta cells. Finally, we demonstrate that CDK4 is activated by glucose through the insulin pathway, ultimately resulting in E2F1 activation and, consequently, increased expression of Kir6.2. In summary we provide evidence that the CDK4-pRB-E2F1 regulatory pathway is involved in glucose homeostasis, defining a new link between cell proliferation and metabolism.
authors: INSERM, U834, Montpellier, F-34298, France.
authors: Jean-Sébastien
authors: JS
authors: Annicotte
authors: Emilie
authors: E
authors: Blanchet
authors: Carine
authors: C
authors: Chavey
authors: Irena
authors: I
authors: Iankova
authors: Safia
authors: S
authors: Costes
authors: Said
authors: S
authors: Assou
authors: Jacques
authors: J
authors: Teyssier
authors: Stéphane
authors: S
authors: Dalle
authors: Claude
authors: C
authors: Sardet
authors: Lluis
authors: L
authors: Fajas
mesh_terms: D000818:Animals; D015153:Blotting, Western; D019556:COS Cells; D002460:Cell Line; D002522:Chlorocebus aethiops; D047369:Chromatin Immunoprecipitation; D051358:Cyclin-Dependent Kinase 4 / Q000378:metabolism*; D050687:E2F1 Transcription Factor / Q000235:genetics / Q000378:metabolism*; D020869:Gene Expression Profiling; D005947:Glucose / Q000494:pharmacology; D007150:Immunohistochemistry; D007328:Insulin / Q000378:metabolism*; D000078790:Insulin Secretion; D007515:Islets of Langerhans / Q000166:cytology / Q000187:drug effects / Q000378:metabolism; D051379:Mice; D008810:Mice, Inbred C57BL; D018345:Mice, Knockout; D008954:Models, Biological; D010766:Phosphorylation; D024661:Potassium Channels, Inwardly Rectifying / Q000235:genetics / Q000378:metabolism; D011485:Protein Binding; D034741:RNA, Small Interfering / Q000235:genetics; D016160:Retinoblastoma Protein / Q000378:metabolism*; D020133:Reverse Transcriptase Polymerase Chain Reaction; D015398:Signal Transduction; D014162:Transfection; D000099161:Kcnj11 Channel
chemical_list: D051358:Cyclin-Dependent Kinase 4; D050687:E2F1 Transcription Factor; D005947:Glucose; D007328:Insulin; D024661:Potassium Channels, Inwardly Rectifying; D034741:RNA, Small Interfering; D016160:Retinoblastoma Protein; D000099161:Kcnj11 Channel; C493754:E2f1 protein, mouse